These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18183549)

  • 41. [Distribution of antigen types of canine parvovirus in Switzerland, Austria and Germany].
    Truyen U; Steinel A; Bruckner L; Lutz H; Möstl K
    Schweiz Arch Tierheilkd; 2000 Mar; 142(3):115-9. PubMed ID: 10748710
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
    Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
    Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus.
    Langeveld JP; Brennan FR; Martínez-Torrecuadrada JL; Jones TD; Boshuizen RS; Vela C; Casal JI; Kamstrup S; Dalsgaard K; Meloen RH; Bendig MM; Hamilton WD
    Vaccine; 2001 Jun; 19(27):3661-70. PubMed ID: 11395200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antigenic analysis of canine parvovirus strains isolated in Italy.
    Buonavoglia D; Cavalli A; Pratelli A; Martella V; Greco G; Tempesta M; Buonavoglia C
    New Microbiol; 2000 Jan; 23(1):93-6. PubMed ID: 10946411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Canine parvovirus infection, canine distemper and infectious canine hepatitis: inclination to vaccinate and antibody response in the Swedish dog population.
    Olson P; Hedhammar A; Klingeborn B
    Acta Vet Scand; 1996; 37(4):433-43. PubMed ID: 9050276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjuvant properties of killed Propionibacterium avidum KP-40 in vaccination of dogs against canine parvovirosis.
    Siwicki AK; Krzyzanowski J; Bartoszcze M; Mizak Z; Paluch S; Szmigielski S; Jeljaszewicz J; Pulverer G
    Dtsch Tierarztl Wochenschr; 1998 May; 105(5):186-90. PubMed ID: 9646552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systemic and local intestinal antibody response in dogs given both infective and inactivated canine parvovirus.
    Nara PL; Winters K; Rice JB; Olsen RG; Krakowka S
    Am J Vet Res; 1983 Nov; 44(11):1989-95. PubMed ID: 6316818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication?
    Decaro N; Buonavoglia C; Barrs VR
    Vet Microbiol; 2020 Aug; 247():108760. PubMed ID: 32768213
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Canine parvovirus immunoprophylaxis: a review.
    Moore DJ
    J S Afr Vet Assoc; 1983 Dec; 54(4):259-64. PubMed ID: 6321731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of a killed feline panleukopenia virus vaccine against canine parvoviral enteritis in dogs.
    Wierup M; Olson P; Hedhammar A; Klingeborn B; Karlsson KA
    Am J Vet Res; 1982 Dec; 43(12):2183-7. PubMed ID: 6299140
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Canine parvovirus infection in dogs: an observation].
    van Aarle PA
    Tijdschr Diergeneeskd; 1986 Dec; 111(24):1279-80. PubMed ID: 3029891
    [No Abstract]   [Full Text] [Related]  

  • 53. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus.
    Jiang W; Baker HJ; Swango LJ; Schorr J; Self MJ; Smith BF
    Vaccine; 1998 Apr; 16(6):601-7. PubMed ID: 9569471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficiency and safety of an inactivated feline parvovirus vaccine against canine parvovirus infection.
    Chapek ML; McClaughry LE; Wilkins LM
    Mod Vet Pract; 1980 Mar; 61(3):261-3. PubMed ID: 7366579
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of antibodies against canine parvovirus and canine distemper virus in wild coyotes in southeastern Colorado.
    Gese EM; Schultz RD; Rongstad OJ; Andersen DE
    J Wildl Dis; 1991 Apr; 27(2):320-3. PubMed ID: 1648628
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982-1991).
    Houston DM; Ribble CS; Head LL
    J Am Vet Med Assoc; 1996 Feb; 208(4):542-6. PubMed ID: 8603904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Canine parvovirus vaccine elicits protection from the inflammatory and clinical consequences of the disease.
    Yule TD; Roth MB; Dreier K; Johnson AF; Palmer-Densmore M; Simmons K; Fanton R
    Vaccine; 1997; 15(6-7):720-9. PubMed ID: 9178474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coagglutination test: a simple and rapid immunodiagnostic test for parvovirus infection in dogs.
    Singh BR; Yadav RC; Singh SP; Sharma VD
    Indian J Exp Biol; 1998 Jun; 36(6):622-4. PubMed ID: 9731477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serologic survey of selected canine pathogens among free-ranging jackals in Kenya.
    Alexander KA; Kat PW; Wayne RK; Fuller TK
    J Wildl Dis; 1994 Oct; 30(4):486-91. PubMed ID: 7760476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serosurvey for selected viral diseases and demography of African wild dogs in Tanzania.
    Creel S; Creel NM; Munson L; Sanderlin D; Appel MJ
    J Wildl Dis; 1997 Oct; 33(4):823-32. PubMed ID: 9391968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.